Immunological factors linked to geographical variation in vaccine responses

MMAR van Dorst, JJ Pyuza, G Nkurunungi… - Nature Reviews …, 2024 - nature.com
Vaccination is one of medicine's greatest achievements; however, its full potential is
hampered by considerable variation in efficacy across populations and geographical …

Controlled human infection models to accelerate vaccine development

RKM Choy, AL Bourgeois… - Clinical Microbiology …, 2022 - Am Soc Microbiol
The timelines for developing vaccines against infectious diseases are lengthy, and often
vaccines that reach the stage of large phase 3 field trials fail to provide the desired level of …

Malaria vaccine efficacy, safety, and community perception in Africa: a scoping review of recent empirical studies

M Chutiyami, P Saravanakumar, UM Bello, D Salihu… - Infection, 2024 - Springer
Aim The review summarizes the recent empirical evidence on the efficacy, safety, and
community perception of malaria vaccines in Africa. Methods Academic Search Complete …

Correlates of malaria vaccine efficacy

DI Stanisic, MBB McCall - Expert Review of Vaccines, 2021 - Taylor & Francis
Introduction: An effective vaccine against malaria forms a global health priority. Both
naturally acquired immunity and sterile protection induced by irradiated sporozoite …

Eosinophils, basophils and myeloid-derived suppressor cells in chronic Loa loa infection and its treatment in an endemic setting

G Burger, R Adamou, R Kreuzmair… - PLOS Neglected …, 2024 - journals.plos.org
Background Chronic infection by Loa loa remains an unsolved immunological paradox.
Despite harboring subcutaneously migrating adult worms and often high densities of …

A CAF01-adjuvanted whole asexual blood-stage liposomal malaria vaccine induces a CD4+ T-cell-dependent strain-transcending protective immunity in rodent …

WA Okoth, MF Ho, M Zaman, E Cooper, P Som… - Mbio, 2023 - Am Soc Microbiol
Malaria is a leading cause of illness and death in children under 5 years of age in Sub-
Saharan Africa. Currently, there is no highly efficacious malaria vaccine capable of inducing …

Immunomodulatory Potential of Non-Classical HLA-G in Infections including COVID-19 and Parasitic Diseases

S Rashidi, C Vieira, R Tuteja, R Mansouri… - Biomolecules, 2022 - mdpi.com
Human Leukocyte Antigen-G (HLA-G), a polymorphic non-classical HLA (HLA-Ib) with
immune-regulatory properties in cancers and infectious diseases, presents both membrane …

Antibody response to malaria vaccine candidates in pregnant women with Plasmodium falciparum and Schistosoma haematobium infections

NA Frempong, A Mama, B Adu, KA Kusi… - Parasite …, 2024 - Wiley Online Library
Malaria in pregnancy has severe consequences for the mother and foetus. Antibody
response to specific malaria vaccine candidates (MVC) has been associated with a …

Evaluation of serum soluble HLA-G levels post-recovery from COVID-19 and post-vaccination (Sinopharm and Pfizer-BioNTech)

RM Hamed, MM Mahmood, AH Ad'hiah - Human Immunology, 2023 - Elsevier
Abstract Serum soluble HLA-G (sHLA-G) levels have been shown to be upregulated in
COVID-19 patients. In this study, sHLA-G levels were examined in COVID-19 patients 14–21 …

[HTML][HTML] Safety, tolerability, and parasite clearance kinetics in controlled human malaria infection after direct venous inoculation of plasmodium falciparum sporozoites …

MF Chughlay, S Chalon, M El Gaaloul… - The American Journal …, 2022 - ncbi.nlm.nih.gov
Plasmodium falciparum sporozoite (PfSPZ) direct venous inoculation (DVI) using
cryopreserved, infectious PfSPZ (PfSPZ Challenge [Sanaria, Rockville, Maryland]) is an …